ABSI
Absci Corp
Key Financials
Revenue
$4.5M
↓ 20.7%
Net Income
$-115183000
↓ 11.7%
Operating Income
$-120317000
↓ 10.5%
Total Assets
$216.3M
↑ 1.3%
Long-term Debt
$4.0M
↓ 49.6%
Total Liabilities
$26.8M
↓ 22.1%
Cash & Equivalents
$20.0M
↓ 51.4%
EPS (Diluted)
$-0.84
↑ 10.6%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13D/A | 4/14/2026 | View on SEC |
| SCHEDULE 13D/A | 3/26/2026 | View on SEC |
| SCHEDULE 13G/A | 3/26/2026 | View on SEC |
| S-8 | 3/24/2026 | View on SEC |
| 10-K | 3/24/2026 | View on SEC |
| 8-K | 3/24/2026 | View on SEC |
| 4/A | 3/16/2026 | View on SEC |
| 4/A | 3/16/2026 | View on SEC |
| 4/A | 3/16/2026 | View on SEC |
| 4/A | 3/16/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ABSI |
| Company Name | Absci Corp |
| CIK | 1672688 |
| Sector | Services-Commercial Physical & Biological Research |
| Industry | Non-accelerated filer Smaller reporting company Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 8731 |
| SIC Description | Services-Commercial Physical & Biological Research |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| Phone | (360) 949-1041 |